CoChat
Sign Up
Cited by 87

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Suppression of tumorigenicity by MicroRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme

Qiu, Shuwei, Huang, Daquan, Yin, Deling, Li, Fangcheng, Li, Xiangping, Kung, Hsiang-fu, Peng, Ying·2013·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
DOI 10.1016/j.bbadis.2013.05.015
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2013.05.015

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 52

  1. Huang, 2009, Oncogenic EGFR signaling networks in glioma, Sci. Signal., 2, 10.1126/scisignal.287re6 · DOI
  2. Preusser, 2011, Current concepts and management of glioblastoma, Ann. Neurol., 70, 9, 10.1002/ana.22425 · DOI
  3. Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  4. Inui, 2010, MicroRNA control of signal transduction, Nat. Rev. Mol. Cell Biol., 11, 252, 10.1038/nrm2868 · DOI
  5. Asadi-Moghaddam, 2010, Potential role of miRNAs and their inhibitors in glioma treatment, Expert. Rev. Anticancer. Ther., 10, 1753, 10.1586/era.10.168 · DOI
  6. Bader, 2010, The promise of microRNA replacement therapy, Cancer Res., 70, 7027, 10.1158/0008-5472.CAN-10-2010 · DOI
  7. Kefas, 2008, MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma, Cancer Res., 68, 3566, 10.1158/0008-5472.CAN-07-6639 · DOI · Paper page
  8. Webster, 2009, Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7, J. Biol. Chem., 284, 5731, 10.1074/jbc.M804280200 · DOI
  9. Kefas, 2009, The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors, J. Neurosci., 29, 15161, 10.1523/JNEUROSCI.4966-09.2009 · DOI
  10. Kefas, 2010, Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells, Neuro Oncol., 12, 1102, 10.1093/neuonc/noq080 · DOI
  11. Gabriely, 2011, Human glioma growth is controlled by microRNA-10b, Cancer Res., 71, 3563, 10.1158/0008-5472.CAN-10-3568 · DOI · Paper page
  12. Crea, 2010, Clinical significance of polycomb gene expression in brain tumors, Mol. Cancer, 9, 265, 10.1186/1476-4598-9-265 · DOI · Paper page
  13. Suva, 2009, EZH2 is essential for glioblastoma cancer stem cell maintenance, Cancer Res., 69, 9211, 10.1158/0008-5472.CAN-09-1622 · DOI
  14. Orzan, 2011, Enhancer of zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells, Neuropathol. Appl. Neurobiol., 37, 381, 10.1111/j.1365-2990.2010.01132.x · DOI
  15. Simon, 2008, Roles of the EZH2 histone methyltransferase in cancer epigenetics, Mutat. Res., 647, 21, 10.1016/j.mrfmmm.2008.07.010 · DOI
  16. Tonini, 2008, Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements, J. Cell. Physiol., 214, 295, 10.1002/jcp.21241 · DOI
  17. Michaud, 2010, Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts, Cancer Res., 70, 3228, 10.1158/0008-5472.CAN-09-4559 · DOI
  18. Chen, 2009, Emerging roles of E2Fs in cancer: an exit from cell cycle control, Nat. Rev. Cancer, 9, 785, 10.1038/nrc2696 · DOI
  19. Alonso, 2005, Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance, J. Natl Cancer Inst., 97, 1589, 10.1093/jnci/dji340 · DOI
  20. Polager, 2008, E2F — at the crossroads of life and death, Trends Cell Biol., 18, 528, 10.1016/j.tcb.2008.08.003 · DOI
  21. Camara-Quintana, 2012, Pathology: commonly monitored glioblastoma markers: EFGR, EGFRvIII, PTEN, and MGMT, Neurosurg. Clin. N. Am., 23, 237, 10.1016/j.nec.2012.01.011 · DOI
  22. Wang, 2011, MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression, Mol. Cancer Res., 9, 1100, 10.1158/1541-7786.MCR-11-0007 · DOI
  23. Rivetti di Val Cervo, 2011, p63-microRNA feedback in keratinocyte senescence, Proc. Natl. Acad. Sci. U. S. A., 109, 1133, 10.1073/pnas.1112257109 · DOI
  24. Siegel, 2009, A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis, Nat. Cell Biol., 11, 705, 10.1038/ncb1876 · DOI · Paper page
  25. Morton, 2008, microRNA-138 modulates cardiac patterning during embryonic development, Proc. Natl. Acad. Sci. U. S. A., 105, 17830, 10.1073/pnas.0804673105 · DOI
  26. Kisliouk, 2011, MiR-138 inhibits EZH2 methyltransferase expression and methylation of histone H3 at lysine 27, and affects thermotolerance acquisition, Eur. J. Neurosci., 33, 224, 10.1111/j.1460-9568.2010.07493.x · DOI
  27. Jiang, 2008, Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma, Int. J. Cancer, 127, 505, 10.1002/ijc.25320 · DOI
  28. Liu, 2011, MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines, Biochem. J., 440, 23, 10.1042/BJ20111006 · DOI
  29. Song, 2011, MiR-138 suppresses expression of hypoxia-inducible factor 1alpha (HIF-1alpha) in clear cell renal cell carcinoma 786-O cells, Asian Pac J Cancer Prev, 12, 1307
  30. Wang, 2012, MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma, Carcinogenesis, 33, 1113, 10.1093/carcin/bgs113 · DOI · Paper page
  31. Zheng, 2012, The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2, Gut, 61, 278, 10.1136/gut.2011.239145 · DOI
  32. Wang, 2011, Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP), Exp. Lung Res., 37, 427, 10.3109/01902148.2011.584263 · DOI
  33. Seike, 2009, MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers, Proc. Natl. Acad. Sci. U. S. A., 106, 12085, 10.1073/pnas.0905234106 · DOI · Paper page
  34. Mitomo, 2008, Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines, Cancer Sci., 99, 280, 10.1111/j.1349-7006.2007.00666.x · DOI
  35. Zhao, 2010, miR-138 might reverse multidrug resistance of leukemia cells, Leuk. Res., 34, 1078, 10.1016/j.leukres.2009.10.002 · DOI · Paper page
  36. Li, 2011, Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas, Omics, 15, 673, 10.1089/omi.2011.0064 · DOI
  37. Chan, 2012, Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas, Cell Rep., 2, 591, 10.1016/j.celrep.2012.07.012 · DOI · Paper page
  38. Brescia, 2012, Current strategies for identification of glioma stem cells: adequate or unsatisfactory?, J. Oncol., 2012, 376894, 10.1155/2012/376894 · DOI
  39. Jiang, 2010, miR-182 as a prognostic marker for glioma progression and patient survival, Am. J. Pathol., 177, 29, 10.2353/ajpath.2010.090812 · DOI
  40. Tucker-Burden, 2012, Lectins identify glycan biomarkers on glioblastoma-derived cancer stem cells, Stem Cells Dev., 21, 2374, 10.1089/scd.2011.0369 · DOI
  41. Chang, 2011, The role of EZH2 in tumour progression, Br. J. Cancer, 106, 243, 10.1038/bjc.2011.551 · DOI
  42. Smits, 2010, miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis, Oncotarget, 1, 710, 10.18632/oncotarget.205 · DOI
  43. Lu, 2011, MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2, Cancer Res., 71, 225, 10.1158/0008-5472.CAN-10-1850 · DOI
  44. Wiedemeyer, 2010, Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM, Proc. Natl. Acad. Sci. U. S. A., 107, 11501, 10.1073/pnas.1001613107 · DOI · Paper page
  45. Silber, 2008, miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells, BMC Med., 6, 14, 10.1186/1741-7015-6-14 · DOI · Paper page
  46. Pierson, 2008, Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma, J. Neurooncol., 90, 1, 10.1007/s11060-008-9624-3 · DOI · Paper page
  47. Berezowska, 2011, Targeting ErbB receptors in high-grade glioma, Curr. Pharm. Des., 17, 2468, 10.2174/138161211797249233 · DOI
  48. Atlas, 2008, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, 455, 1061, 10.1038/nature07385 · DOI · Paper page
  49. Wu, 2010, Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression, Cell Death Differ., 17, 801, 10.1038/cdd.2009.162 · DOI
  50. Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
  51. Cha, 2005, Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3, Science, 310, 306, 10.1126/science.1118947 · DOI
  52. Chen, 2010, Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2, Nat. Cell Biol., 12, 1108, 10.1038/ncb2116 · DOI

Cited by

Sorted by citations

See all 87

Metadata

Authors
Qiu, S., Huang, D., Yin, D., Li, F., Li, X., Kung, H.-F., & Peng, Y.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2013-10
Volume
1832
Issue
10
Pages
1697-1707
ISSN
0925-4439
DOI
10.1016/j.bbadis.2013.05.015
Cited by
87
References
2
Language
en
Licence
Funders
  • National Natural Science Foundation of China (81272197, 30973479 and 31070953)
  • Oversea Collaboration Grant of NSFC, China (81228010)
  • International Collaboration Program of Universities in Guangdong Province (2012gjhz001)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review